6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations

Size: px
Start display at page:

Download "6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations"

Transcription

1 CLOSTRIDIUM DIFFICILE PREVENTION Beth Goodall, RN, BSN Board Certified in Infection Prevention and Control DCH Health System Epidemiology Director Welcome! Teaming Up to Prevent Infections! CLOSTRIDIUM DIFFICILE PRESENTATION OUTLINE 1) Impact 2) Testing Recommendations 3) Prevention 1

2 BACKGROUND: PATHOGENESIS OF CDI 1. Ingestion of spores transmitted from other patients via the hands of healthcare personnel and environment 3. Altered lower intestine flora (due to antimicrobial use) allows 4. Toxin A & B Production proliferation of leads to colon damage C. difficile in colon +/- pseudomembrane 2. Germination into growing (vegetative) form Sunenshine et al. Cleve Clin J Med. 2006;73: BACKGROUND: EPIDEMIOLOGY RISK FACTORS Antimicrobial exposure Acquisition of C. difficile Advanced age Underlying illness Immunosuppression Tube feeds Gastric acid suppression Main modifiable risk factors Nursing Home 2

3 C. difficile germs move with patients from one health care facility to another, infecting other patients. o The most dangerous source of spread to others is the patients with diarrhea. o Unnecessary antibiotic use in patients at one facility may increase the spread of C. diff. in another facility when patients transfer. o When patient transfers, it is not always communicated that the patient has or recently had C. diff. infection, so they may not be taking the right actions to prevent spread. RISK OF CLOSTRIDIUM DIFFICILE While C difficile is the most commonly recognized cause of antibiotic-associated diarrhea, it accounts for only 15%-25% of all such diarrheal episodes. Likelihood is increased if the patient has received antibiotics in the previous 8-12 weeks, is over 65 years of age, and has 3 or more diarrheal stools in a 24-hour period. BACKGROUND: IMPACT Campbell et al. Infect Control Hosp Epidemiol. 2009:30: ;14: Dubberke et al. Clin Infect Dis. 2008;46: Brief # Hospital-acquired, hospitalonset: 165,000 cases, $1.3 billion in excess costs, and 9,000 deaths annually Hospital-acquired, postdischarge (up to 4 weeks): 50, cases, $0.3 billion in excess costs, and 3,000 deaths annually Nursing home-onset: 263,000 cases, $2.2 billion in excess costs, and 16,500 deaths annually Dubberke et al. Emerg Infect Dis. Elixhauser et al. HCUP Statistical 3

4 DEATHS CAUSED BY C. DIFFICILE INFECTIONS 400% rise from 2000 to 2007 Up to 14,000 deaths annually $1.3 billion in extra cost Source: CDC National Center for Health Statistics 2012 TESTING FOR CLOSTRIDIUM DIFFICILE INFECTION It is important to ensure that only patients with active diarrhea are being tested; otherwise, the tests are more likely to detect asymptomatic colonization. Moreover, patients who have recovered from CDI will often remain colonized for a prolonged period, and therefore repeat testing of patients to prove cure should be discouraged. DIAGNOSTIC TESTING METHODS Most laboratories have relied on Toxin A/B enzyme immunoassays - EIA Low sensitivities (70-80%) lead to low negative predictive value Poor test ordering practices (i.e. testing formed stool or repeat testing in negative patients) ts) may lead to many false positives Cost $5 Consider more sensitive diagnostic testing, PCRbased molecular assay Highly sensitive, > 90% 10% of PCR+ are probably colonized rather than infected Cost $25 - $50 4

5 COLONIZATION VS. INFECTION Clostridium difficile colonization Patient exhibits NO clinical symptoms Patient tests positive for Clostridium difficile More common than infection Clostridium difficile infection Patient exhibits clinical symptoms Patient test positive for Clostridium difficile CLOSTRIDIUM DIFFICILE INFECTIONS CAN BE PREVENTED. DOCTORS AND NURSES Prescribe antibiotics carefully. Once culture results are available, make sure abx are correct and necessary. Order testing only if >3 unformed stools in 24h. Be aware of infection rates in your facility. Isolate patients with C. diff immediately. Clean room surfaces with bleach. When a patient transfers, notify the new facility. Wear gloves and gowns. Wash hands with soap and water. 5

6 SUPPLEMENTAL PREVENTION STRATEGIES: RATIONALE FOR SOAP AND WATER: LACK OF EFFICACY OF ALCOHOL-BASED HANDRUB AGAINST C. DIFFICILE Oughton et al. Infect Control Hosp Epidemiol 2009;30: FACILITY ADMINISTRATORS Support better testing, tracking, and reporting of infection prevention efforts. Make sure cleaning staff follows CDC guidelines, using spore-killing disinfectant in C. diff patient rooms. Notify other health care facilities about infectious diseases when patients transfer, especially between hospitals and nursing homes. Participate in regional prevention efforts. PATIENTS Take antibiotics only as prescribed by your doctor. Antibiotics can be lifesaving medicines. Tell your doctor if you gave been on antibiotics and get diarrhea within a few months. Wash your hands after using the bathroom. Try to use a separate bathroom if you have diarrhea, or be sure the bathroom is cleaned well. 6

7 SUMMARY OF PREVENTION MEASURES Core Measures Contact Precautions for duration of illness Hand hygiene in compliance with CDC/WHO Cleaning and disinfection of equipment and environment Laboratory-based alert system CDI surveillance Education Supplemental Measures Prolonged duration of Contact Precautions* Presumptive isolation Evaluate and optimize testing Soap and water for HH upon exiting CDI room Universal glove use on units with high CDI rates* Bleach for environmental disinfection Antimicrobial stewardship program * Not included in CDC/HICPAC 2007 Guideline for Isolation Precautions CLOSTRIDIUM DIFFICILE -THE BOTTOM LINE Given that both the incidence and severity of CDI are at historic highs, it is important that clinicians become more aware of how to recognize, diagnose, treat, and prevent CDI. CDI can be prevented by washing hands with soap and water between patients, wearing gloves and gowns when entering rooms of patients with diarrhea, and using antibiotics judiciously. Go Forth... 7

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose?

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist

More information

Activity C: ELC Prevention Collaboratives

Activity C: ELC Prevention Collaboratives Clostridium difficile il (CDI) Infections Toolkit Activity C: ELC Prevention Collaboratives Carolyn Gould, MD MSCR Cliff McDonald, MD, FACP Division of Healthcare Quality Promotion Centers for Disease

More information

C Difficile - The Ultimate Challenge: Controlling the Spread

C Difficile - The Ultimate Challenge: Controlling the Spread C Difficile - The Ultimate Challenge: Controlling the Spread Linda R. Greene, RN, MPS, CIC Manager of Infection Prevention Highland Hospital Rochester, NY University of Rochester Medical Center linda_greene@urmc.rochester.edu

More information

Clostridium difficile Infection: Diagnosis and Management

Clostridium difficile Infection: Diagnosis and Management Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,

More information

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool

More information

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated

More information

Clostridium difficile: An Overview

Clostridium difficile: An Overview Clostridium difficile: An Overview CDI Webinar July 11, 2017 PUBLIC HEALTH DIVISION Acute and Communicable Disease Prevention Section Outline Background Microbiology Burden Pathogenesis Diagnostic testing

More information

Clostridium difficile Essential information

Clostridium difficile Essential information Clostridium difficile Essential information Clostridium difficile Origins Clostridium difficile (C. diff) is a Gram positive, spore forming, anaerobic bacterium with a rod structure. It was first identified

More information

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection

More information

Los Angeles County Department of Public Health: Your Partner in CDI Prevention

Los Angeles County Department of Public Health: Your Partner in CDI Prevention Los Angeles County Department of Public Health: Your Partner in CDI Prevention Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health dterashita@ph.lacounty.gov

More information

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE

More information

C. Difficile Testing Protocol

C. Difficile Testing Protocol C. Difficile Testing Protocol Caroline Donovan, RN, BSN, ONC- Infection Control Practitioner Abegail Pangan, RN, MSN, CIC- Infection Control Practitioner U.S. NEWS & WORLD REPORT 2017 2018 RANKINGS Acute

More information

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH Some history first Clostridium difficile, a spore-forming gram-positive (i.e., thick

More information

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers Disclosures No conflict of interest to declare Acknowledgments Objectives and Agenda Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Guidelines

More information

Modern approach to Clostridium Difficile Infection

Modern approach to Clostridium Difficile Infection Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research

More information

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment. C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin

More information

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual

More information

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile Infection (CDI) Management Guideline Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for

More information

C. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors

C. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors C. difficile: The Changing Epidemiology Ghinwa Dumyati, MD University of Rochester Monroe County Department of Public Health Thank You to our Sponsors Evaluations School of Public Health, University at

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence

More information

Understanding C. diff. atomalliance.org/cdifftraining

Understanding C. diff. atomalliance.org/cdifftraining Understanding C. diff atomalliance.org/cdifftraining This booklet is a printed guide of the online educational resource atomalliance.org/cdifftraining Target Audience Understanding C. diff This educational

More information

Getting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013

Getting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013 Tackling Clostridium difficile in Nursing Homes Getting to Know You Emily Lutterloh, MD, MPH Director, Bureau of Healthcare Associated Infections New York State Department of Health Outline Getting to

More information

Clostridioides difficile Infection: What s the BIG Stink?

Clostridioides difficile Infection: What s the BIG Stink? Clostridioides difficile Infection: What s the BIG Stink? GLORIA MATHIS, RN, BSN, CIC 29 TH ANNUAL MEDICAL SURGICAL CONFERENCE APRIL 4, 2019 SAN FRANCISCO, CA I am sre my patient has C. diff. I cold smell

More information

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection Issue Date: June 2013 Vol. 8 No. 6 Author: Amy Marinski, MSN, RN, CCRN, CNL More than 3 million new cases of Clostridium

More information

A Pharmacist Perspective

A Pharmacist Perspective Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed

More information

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Istituto Nazionale per le Malattie Infettive «lazzaro Spallanzani», IRCCS-Roma The infectious cycle of transmission

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Infection Control Team Patient Information Leaflet What is Clostridium difficile? Clostridium difficile (sometimes called C. diff) is a type of bacteria. They live in the intestine

More information

Clostridium difficile infection surveillance: Applying the case definition

Clostridium difficile infection surveillance: Applying the case definition Clostridium difficile infection surveillance: Applying the case definition PICNet Conference March 3 rd 2016 Presented by: Tara Leigh Donovan, MSc Managing Consultant (Former Epidemiologist) 1 Disclaimer

More information

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI L. Clifford McDonald, MD Lance R. Peterson, MD March 27, 2012 1 Potential COI L. Clifford McDonald,

More information

Prevention and Control of Healthcare-Associated Norovirus

Prevention and Control of Healthcare-Associated Norovirus Purpose: Audience: Policy: To prevent healthcare-associated norovirus infections in patients, employees, contract workers, volunteers, visitors and students and to control and eradicate norovirus infections

More information

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for

More information

EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI)

EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics & Epidemiology Associate Chief Medical Offer, UNC Health Care Medical

More information

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES California Department of Health Services Division of Communicable Disease Control In Conjunction with Licensing and Certification

More information

An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings

An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings About APIC APIC s mission is to improve health and patient safety by reducing risks of infection and other adverse

More information

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Chapter 19 Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Key Points Noroviruses are the commonest cause of healthcare-associated gastroenteritis. Isolation

More information

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg?

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg? Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg? Disclosures Merck Canada, BD Diagnostics, AMD Medical, Canadian Institute for Health Research Merck Canada, Pfizer OBJECTIVES

More information

CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08

CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08 CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08 The growth of infections caused by Clostridium difficile (C.diff) is a highly alarming trend in hospitals today. In 1993

More information

2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key

2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key Name: School: Instructor: Date: 2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key For questions about this test, contact Infection Prevention and Control at 678-312-3308. 1. When do you

More information

Preventing & Controlling the Spread of Infection

Preventing & Controlling the Spread of Infection Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of

More information

Clostridium difficile Diagnostic and Clinical Challenges

Clostridium difficile Diagnostic and Clinical Challenges Papers in Press. Published December 11, 2015 as doi:10.1373/clinchem.2015.243717 The latest version is at http://hwmaint.clinchem.org/cgi/doi/10.1373/clinchem.2015.243717 Clinical Chemistry 62:2 000 000

More information

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known

More information

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile OBJECTIVES HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile Identify and describe the pathophysiology of C. diff. Identify and describe current therapies in treatment of C. diff Identify

More information

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium

More information

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015 Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division

More information

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections Christina M. Surawicz, MD 1, Lawrence J. Brandt, MD 2, David G. Binion, MD 3, Ashwin N. Ananthakrishnan,

More information

What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach

What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach GHA Learning & Action Network - 01/13/16 Russ Olmsted Dir., Infection Prevention & Control (IPC) System Office, Livonia olmstedr@trinity-health.org

More information

HRET HIIN Diagnostic Error Virtual Event

HRET HIIN Diagnostic Error Virtual Event HRET HIIN Diagnostic Error Virtual Event Promoting Diagnostic Stewardship: Effectively Reducing Diagnostic Errors September 19, 2017 1 Jordan Steiger, MPH Program Manager, HRET WELCOME AND INTRODUCTIONS

More information

SARS Infection Control in Healthcare Settings

SARS Infection Control in Healthcare Settings SARS Infection Control in Healthcare Settings William A. Rutala, Ph.D., M.P.H. University of North Carolina (UNC) Hospitals and UNC School of Medicine Infection Control Considerations Hospitals must protect

More information

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary Course: Patient Safety Solutions Topic: Infection prevention and control Summary Health care-associated Infection (HCAI) is defined as an infection acquired in a hospital by a patient who was admitted

More information

Clostridium Difficile Infection in Adults Treatment and Prevention

Clostridium Difficile Infection in Adults Treatment and Prevention Clostridium Difficile Infection in Adults Treatment and Prevention Definition: Clostridium Difficile colonizes the human intestinal tract after the normal gut flora has been altered by antibiotic therapy

More information

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening There s an updated Annex C Annex C is an extension to the PIDAC Infection Prevention

More information

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and

More information

Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures?

Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures? Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures? Clostridium difficile Clostridium difficile - first described in 1935 when it was isolated

More information

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back.

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back. Do you have severe diarrhea? It could be a potentially serious infection known as C diff, caused by the bacteria Clostridium difficile. In some people, C diff can come back. Not an actual patient. ZINPLAVA

More information

FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING CONTAGIOUS!!!!!!!!!!!!!!!!!!!!!!!!!!!

FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING CONTAGIOUS!!!!!!!!!!!!!!!!!!!!!!!!!!! FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING CONTAGIOUS!!!!!!!!!!!!!!!!!!!!!!!!!!! It s contagious!! HANDWASHING TO ATTACK NOROVIRUS!! HELP FIGHT INFECTIOUS BACTERIA AND VIRUSES MAKE HANDWASHING

More information

Round Robin Highlights of Infection Control Practices

Round Robin Highlights of Infection Control Practices Round Robin Highlights of Infection Control Practices Arkansas Department of Health Healthcare-Associated Infections Program Staff To Isolate or Not To Isolate: That Is The Question Kelley Garner, MPH,

More information

MDROs and other exciting things What You Need to Know in Long-Term Care

MDROs and other exciting things What You Need to Know in Long-Term Care MDROs and other exciting things What You Need to Know in Long-Term Care 1 April 12, 2018 Toni Foos, RN, BSN, CIC Infection Prevention Manager Colorado Hospital Association Today s Call is Provided by Telligen

More information

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Financial Disclosures No financial disclosures Objectives Review a case of recurrent Clostridium difficile infection

More information

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit GASTROENTERITIS DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest within this presentation fidaxomicin (which

More information

Hand Hygiene: Preventing avoidable harm in our care

Hand Hygiene: Preventing avoidable harm in our care Hand Hygiene: Preventing avoidable harm in our care Hand Hygiene Training Presentation for Healthcare Workers in Community and Primary Care National HSE HCAI AMR Clinical Programme 2017 What we will cover

More information

A WINK WILL MAKE YOU THINK.. Infection Control and Prevention: Transmission-Based Precautions

A WINK WILL MAKE YOU THINK.. Infection Control and Prevention: Transmission-Based Precautions A WINK WILL MAKE YOU THINK.. Infection Control and Prevention: Transmission-Based Precautions This WINK must be completed by: All staff members with direct patient contact Objectives: Verbalize methods

More information

TITLE OF PRESENTATION

TITLE OF PRESENTATION TITLE OF PRESENTATION Can C. Subtitle difficile of Infection Presentation Rates Be Used to Judge Prevention Success for Hospitals? David P. Calfee, MD, MS Associate Professor of Medicine and Public Health

More information

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast

More information

Clostridium difficile Infection (CDI) Guideline Update:

Clostridium difficile Infection (CDI) Guideline Update: Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH A Webinar for HealthTrust Members Professor of Medicine September 24,

More information

Clostridium Difficile colitismore

Clostridium Difficile colitismore Clostridium Difficile colitismore virulent than ever ECHO- February 18, 2016 Charles Krasner, M.D. UNR School of Medicine Sierra NV Veterans Affairs Hospital Growing problem of pseudomembranous colitis

More information

Human Microbiome in state of health and illness.

Human Microbiome in state of health and illness. Human Microbiome in state of health and illness. Objectives: 1) To recognize what fuels the plaque of Century 2) To understand the interaction between microbiome and human in health and disease states(dysbiosis)

More information

ABSTRACT PURPOSE METHODS

ABSTRACT PURPOSE METHODS ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection

More information

2018 UPDATE. INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS

2018 UPDATE. INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS 2018 UPDATE INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection Prevention and Control Assistant Professor

More information

Infection Prevention and Control

Infection Prevention and Control Patient & Family Guide Infection Prevention and Control 2017 Aussi disponible en français : Prévention et contrôle des infections (FF85-1216) www.nshealth.ca Infection Prevention and Control Who are we?

More information

more intense treatments are needed to get rid of the infection.

more intense treatments are needed to get rid of the infection. What Is Clostridium Difficile (C. Diff)? Clostridium difficile, or C. diff for short, is an infection from a bacterium that can grow in your intestines and cause bad GI symptoms. The main risk of getting

More information

Hand Hygiene for Clinical Staff

Hand Hygiene for Clinical Staff Hand Hygiene for Clinical Staff Volunteer Annual Review 2017 Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! What is Hand Hygiene? Hand Hygiene means cleaning

More information

HealthStream Regulatory Script

HealthStream Regulatory Script HealthStream Regulatory Script [Transmission-Based Precautions: Contact and Droplet] Version: [April 2005] Lesson 1: Introduction Lesson 2: Contact Precautions Lesson 3: Droplet Precautions Lesson 1: Introduction

More information

2019 UPDATE 1/9/ ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS. Healthcare-Associated Infections (HAIs) INFECTION PREVENTION and CONTROL

2019 UPDATE 1/9/ ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS. Healthcare-Associated Infections (HAIs) INFECTION PREVENTION and CONTROL DC* DC* 219 UPDATE INFECTION PREVENTION and CONTROL Healthcare-Associated Infections (HAIs) ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection

More information

WELCOME TO Scott &White Infection Prevention

WELCOME TO Scott &White Infection Prevention WELCOME TO Scott &White Infection Prevention Scott and White Needs YOU To prevent infections to patients Hand washing is the single best way to keep from spreading infections or germs to others! Preventable

More information

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015 DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News Volume 3, Number 6, June 2015 Diagnostic Testing for Clostridium difficile Infection Background Clostridium difficile

More information

Loyola s C diff Journey

Loyola s C diff Journey Loyola s C diff Journey Kevin Smith, MD Associate Chief Medical Officer, Quality & Safety Aziz Ansari, DO Associate Chief Medical Officer, Clinical Optimization/Revenue Integrity Background Loyola Medicine

More information

C. DIFF QUIK CHEK COMPLETE. Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE NEXT PAGE

C. DIFF QUIK CHEK COMPLETE. Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE NEXT PAGE C. DIFF QUIK CHEK COMPLETE Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE PAGE CLINICIAN Would actionable C. difficile test results in less than 30 minutes improve patient

More information

CDC Health Advisory 04/29/2009

CDC Health Advisory 04/29/2009 H1N1 (Swine Flu) is a sub-type of Influenza A. Wexford Labs disinfectants are effective against Influenza A. Current CDC Recommendations for Environmental Control in the Healthcare Setting: CDC Health

More information

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 48 Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others Authors Olivier Vandenberg, MD, PhD Michèle

More information

Bloodborne Pathogens. Kathleen Stefek, RN, MSN

Bloodborne Pathogens. Kathleen Stefek, RN, MSN Bloodborne Pathogens Kathleen Stefek, RN, MSN What are Bloodborne Pathogens? Infectious agents carried in the blood and other body fluids that are capable of infecting a host (people like you and me) with

More information

Chapter 12 Preventing Infection

Chapter 12 Preventing Infection Chapter 12 Preventing Infection Infection is a major safety and health hazard. Minor infections cause acute illnesses and some infections are serious and can cause death. Microbe/microorganism is a small

More information

Dangers of NOT Cleaning Your Hands

Dangers of NOT Cleaning Your Hands Hand Hygiene Basics Hand Hygiene Simplest and MOST effective way to stop spreading infections Breaks the chain of spreading infections from person to person Kills or stops the growth of many organisms

More information

Katie Obergfell BSN, RN CIC Karen Brody BSN, RN

Katie Obergfell BSN, RN CIC Karen Brody BSN, RN Katie Obergfell BSN, RN CIC Karen Brody BSN, RN Purpose of Infection Prevention Chain of Infection Standard Precautions Multi-Drug Resistant Organisms Isolation Procedures Blood borne Pathogens TB Employee

More information

Confronting Ebola. Keeping NY patients and healthcare workers safe and healthy

Confronting Ebola. Keeping NY patients and healthcare workers safe and healthy Confronting Ebola Keeping NY patients and healthcare workers safe and healthy All materials provided by Centers for Disease Control and Prevention. October 16, 2014 What You Need to Know about Ebola The

More information

Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home

Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home The following is a summary of guidelines developed to

More information

Norovirus in Healthcare Settings

Norovirus in Healthcare Settings ST. JAMES HEALTHCARE DECEMBER 2012 INFECTION PREVENTION NEWSLETTER INSIDE THIS ISSUE: Norovirus in Healthcare Settings The Impacts of Unsafe Medical Injections in the U.S. Preparing Your Skin Before Surgery:

More information

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB Infection control in Aged Residential Care Facilities Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB Background Endemic infections Epidemic infections Managing outbreaks Administrative measures

More information

Principles and Practices of Asepsis

Principles and Practices of Asepsis Module E Objectives Principles and Practices of Asepsis Role of hands and the environment in disease transmission Describe the principles and practice of asepsis Understand hand hygiene Understand the

More information

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma

More information

VIII Congresso Nazionale Maggio 2018

VIII Congresso Nazionale Maggio 2018 VIII Congresso Nazionale Attualità e prospettive nella prevenzione e controllo delle infezioni nelle organizzazioni sanitarie 21-23 Maggio 2018 Bergamo, Ospedale Papa Giovanni XXIII Clostridium difficile

More information

Infection Control Sec. 1, Unit 5 Part 1

Infection Control Sec. 1, Unit 5 Part 1 Infection Control Sec. 1, Unit 5 Part 1 Introduction Infections are a significant cause of illness, disease and death for residents that reside in certain living situations including nursing facilities.

More information

CLOSTRIDIUM DIFFICILE

CLOSTRIDIUM DIFFICILE Other useful information sources NHS Choices: www.nhs.uk NHS 111 (for urgent medical help that is not a 999 emergency) Public Health England: www.phe.gov.uk National Patient Safety Agency - www.npsa.nhs.uk/cleanyourhands

More information

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through

More information

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through

More information

Clostridium difficile Infections

Clostridium difficile Infections Educational Module for Nurses in Long-term Care Facilities: Preventing and Managing Clostridium difficile Infections Clostridium difficile (C. difficile) causes a wide range of illness - from uncomplicated

More information

Patient & Family Guide. Norovirus. Aussi disponible en français : Norovirus (FF )

Patient & Family Guide. Norovirus. Aussi disponible en français : Norovirus (FF ) Patient & Family Guide Norovirus 2017 Aussi disponible en français : Norovirus (FF85-1855) www.nshealth.ca Norovirus What is norovirus? Norovirus is a common fall and winter virus. Some people may refer

More information

Infection Preventionist Series

Infection Preventionist Series Infection Preventionist Series Webinar 5: Frequent Citations: What Are We Missing? Diane Dohm MT, IP, CIC, CPHQ MetaStar April 3, 2018 Infection Preventionist Series Surveillance What data should we collect?

More information

Safe Patient Care Keeping our Residents Safe

Safe Patient Care Keeping our Residents Safe Safe Patient Care Keeping our Residents Safe 2016 Diarrhoea & Vomiting Infection Prevention & Control in Residential Care Setting Patricia Coughlan, Infection Prevention Control Nurse, HSE Disability Services

More information

Probiotics for Primary Prevention of Clostridium difficile Infection

Probiotics for Primary Prevention of Clostridium difficile Infection Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss

More information